For: | Wang P, Zhang X, Shao SH, Wu F, Du FZ, Zhang JF, Zuo ZW, Jiang R. Chemotherapy, transarterial chemoembolization, and nephrectomy combined treated one giant renal cell carcinoma (T3aN1M1) associated with Xp11.2/TFE3: A case report. World J Clin Cases 2022; 10(28): 10180-10185 [PMID: 36246795 DOI: 10.12998/wjcc.v10.i28.10180] |
---|---|
URL: | https://www.wjgnet.com/2307-8960/full/v10/i28/10180.htm |
Number | Citing Articles |
1 |
Denghao Yang, Wen Tang, Mingwen Liu, Zhifei Xie, Fei Shi, Zeju Zhao, Xiaorong Yang, Tao Wu. Renal cell carcinoma associated with Xp11.2 translocation/transcription factor E3 gene fusion: A case report and literature review. Oncology Letters 2023; 27(1) doi: 10.3892/ol.2023.14162
|
2 |
Yin-Miao Bai, Li Yang, Yue Yang, Xiang-Xu Wang, Meng-Di Zheng, Xiao Chai, Qiong-Yi Dou, Hong-Mei Zhang. The Clinicopathological Characteristics and Prognosis of 55 Patients With TFE3-Rearranged Renal Cell Carcinomas. Clinical Genitourinary Cancer 2024; 22(5): 102165 doi: 10.1016/j.clgc.2024.102165
|